More compact doses for perioral treatment than for upper facial purposes are utilised given that the oral musculature responds additional strongly to the same BTX-A dosing. Only one preparing of botulinum toxin type B (MyoBloc®/NeuroBloc®) exists. Its sole indicator and FDA approval lies in treatments of cervical dystonia.The blockage of acetylch